New Market Report: Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Oct. 10, 2011 - PRLog -- Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Summary

GlobalData, the industry analysis specialist, has released its new report, "Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Multiple Myeloma Therapeutics market. The report identifies the key trends shaping and driving the global Multiple Myeloma Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Multiple Myeloma Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/234151_multiple_myeloma_therap...
------------------------------------------------------------

Scope

The report provides information on the key drivers and challenges of the Multiple Myeloma Therapeutics market. Its scope includes -

* Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Multiple Myeloma Therapeutics  market revenues data from 2005 to 2010, forecast for eight years to 2018.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
* Analysis of the current and future competition in the seven key countries Multiple Myeloma Therapeutics market.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Multiple Myeloma Therapeutics market.
* Analysis of key recent licensing and partnership agreements in Multiple Myeloma Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Multiple Myeloma Therapeutics market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Multiple Myeloma Therapeutics market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Multiple Myeloma Therapeutics market landscape? - Identify, understand and capitalize.


Partial Table of Contents:

1 Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Multiple Myeloma Therapeutics - Introduction
2.1 Disease Overview
2.2 Epidemiology
2.3 Etiology and Risk Factors
2.4 Symptoms
2.5 Diagnosis
2.5.1 M Band Electrophoresis
2.5.2 Complete Blood Count (CBC)
2.5.3 Quantitative Immunoglobulins
2.5.4 Blood Chemistry Test
2.5.5 Bone X-Rays
2.5.6 Computerized Tomography (CT)
2.5.7 Magnetic Resonance Imaging (MRI
2.5.8 Positron Emission Tomography (PET)
2.5.9 Bone Marrow Biopsy
2.6 Staging for Multiple Myeloma
2.6.1 Durie-Salmon System of Staging
2.6.2 International Staging System
2.6.3 Other Stages of Multiple Myeloma
2.7 Treatment for Multiple Myeloma
2.7.1 Chemotherapy
2.7.2 Immunotherapy
2.7.3 Radiation Therapy
2.7.4 Bone Marrow Transplants
2.7.5 Stem Cell Transplants
2.8 GlobalData Pipeline Report Guidance
3 Multiple Myeloma Therapeutics - Market Characterization
3.1 Multiple Myeloma Therapeutics Market Size (2005-2010) - Global
3.2 Multiple Myeloma Therapeutics Market Forecast (2010-2018) - Global
3.3 Multiple Myeloma Therapeutics Market Size (2005-2010) - The US
3.4 Multiple Myeloma Therapeutics Market Forecast (2010-2018) - The US
3.5 Multiple Myeloma Therapeutics Market Size (2005-2010) - The UK
3.6 Multiple Myeloma Therapeutics Market Forecast (2010-2018) - The UK
3.7 Multiple Myeloma Therapeutics Market Size (2005-2010) - France
3.8 Multiple Myeloma Therapeutics Market Forecast (2010-2018) - France
3.9 Multiple Myeloma Therapeutics Market Size (2005-2010) - Germany
3.10 Multiple Myeloma Therapeutics Market Forecast (2010-2018) - Germany
3.11 Multiple Myeloma Therapeutics Market Size (2005-2010) - Italy
3.12 Multiple Myeloma Therapeutics Market Forecast (2010-2018) - Italy
3.13 Multiple Myeloma Therapeutics Market Size (2005-2010) - Spain
3.14 Multiple Myeloma Therapeutics Market Forecast (2010-2018) - Spain
3.15 Multiple Myeloma Therapeutics Market Size (2005-2010) - Japan
3.16 Multiple Myeloma Therapeutics Market Forecast (2010-2018) - Japan
3.17 Drivers and Barriers for the Multiple Myeloma Therapeutics Market
3.17.1 Drivers for the Multiple Myeloma Therapeutics Market
3.17.2 Barrier for the Multiple Myeloma Therapeutics Market
3.18 Opportunity and Unmet Need Analysis

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=2341...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.